Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation
- PMID: 7834738
- DOI: 10.1016/0092-8674(95)90401-8
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation
Abstract
A number of different intracellular signaling pathways have been shown to be activated by receptor tyrosine kinases. These activation events include the phosphoinositide 3-kinase, 70 kDa S6 kinase, mitogen-activated protein kinase (MAPK), phospholipase C-gamma, and the Jak/STAT pathways. The precise role of each of these pathways in cell signaling remains to be resolved, but studies on the differentiation of mammalian PC12 cells in tissue culture and the genetics of cell fate determination in Drosophila and Caenorhabditis suggest that the extracellular signal-regulated kinase (ERK-regulated) MAPK pathway may be sufficient for these cellular responses. Experiments with PC12 cells also suggest that the duration of ERK activation is critical for cell signaling decisions.
Similar articles
-
Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases.Oncogene. 1997 Apr 10;14(14):1635-42. doi: 10.1038/sj.onc.1201000. Oncogene. 1997. PMID: 9135064
-
Phosphotyrosine residues in the nerve-growth-factor receptor (Trk-A). Their role in the activation of inositolphospholipid metabolism and protein kinase cascades in phaeochromocytoma (PC12) cells.Eur J Biochem. 1995 Nov 15;234(1):84-91. doi: 10.1111/j.1432-1033.1995.084_c.x. Eur J Biochem. 1995. PMID: 8529673
-
Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.Biochem J. 1996 Apr 15;315 ( Pt 2)(Pt 2):517-22. doi: 10.1042/bj3150517. Biochem J. 1996. PMID: 8615823 Free PMC article.
-
CSF-1 signal transduction.J Leukoc Biol. 1997 Aug;62(2):145-55. doi: 10.1002/jlb.62.2.145. J Leukoc Biol. 1997. PMID: 9261328 Review.
-
Signaling by dual specificity kinases.Oncogene. 1998 Sep 17;17(11 Reviews):1447-55. doi: 10.1038/sj.onc.1202251. Oncogene. 1998. PMID: 9779990 Review.
Cited by
-
MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models.Childs Nerv Syst. 2024 May 25. doi: 10.1007/s00381-024-06463-z. Online ahead of print. Childs Nerv Syst. 2024. PMID: 38789691
-
Oncogenic Kras induces spatiotemporally specific tissue deformation through converting pulsatile into sustained ERK activation.Nat Cell Biol. 2024 Jun;26(6):859-867. doi: 10.1038/s41556-024-01413-y. Epub 2024 Apr 30. Nat Cell Biol. 2024. PMID: 38689013
-
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance.Curr Oncol. 2024 Apr 3;31(4):2024-2046. doi: 10.3390/curroncol31040150. Curr Oncol. 2024. PMID: 38668053 Free PMC article. Review.
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
ERK-activated CK-2 triggers blastema formation during appendage regeneration.Sci Adv. 2024 Mar 22;10(12):eadk8331. doi: 10.1126/sciadv.adk8331. Epub 2024 Mar 20. Sci Adv. 2024. PMID: 38507478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous